151 related articles for article (PubMed ID: 38700731)
1. A Multicenter Prospective Randomized Controlled Trial Comparing Cxbladder Triage to Cystoscopy in Patients With Microhematuria: The Safe Testing of Risk for Asymptomatic Microhematuria Trial.
Lotan Y; Daneshmand S; Shore N; Black P; Scarpato KR; Patel A; Lough T; Shoskes DA; Raman JD
J Urol; 2024 Jul; 212(1):41-51. PubMed ID: 38700731
[TBL] [Abstract][Full Text] [Related]
2. Budgetary Impact of Including the Urinary Genomic Marker Cxbladder Detect in the Evaluation of Microhematuria Patients.
Tyson MD; Abouassaly R; Durant A; Smith AB; Seemann K; Shoskes DA
Urol Pract; 2024 Jan; 11(1):54-60. PubMed ID: 37914255
[TBL] [Abstract][Full Text] [Related]
3. Inclusion of a molecular marker of bladder cancer in a clinical pathway for investigation of haematuria may reduce the need for cystoscopy.
Davidson PJ; McGeoch G; Shand B
N Z Med J; 2019 Jun; 132(1497):55-64. PubMed ID: 31220066
[TBL] [Abstract][Full Text] [Related]
4. Urinary Analysis of
Lotan Y; Raman JD; Konety B; Daneshmand S; Schroeck F; Shariat SF; Black P; de Lange M; Asroff S; Goldfischer E; Efros M; Chong KT; Huang E; Chua HL; Wu QH; Yeow S; Lau W; Yong J; Eng M
J Urol; 2023 Apr; 209(4):762-772. PubMed ID: 36583640
[TBL] [Abstract][Full Text] [Related]
5. Assessment of a clinical pathway for investigation of haematuria that reduces the need for cystoscopy.
Davidson PJ; McGeoch G; Shand B
N Z Med J; 2020 Dec; 133(1527):71-82. PubMed ID: 33332329
[TBL] [Abstract][Full Text] [Related]
6. The Diagnostic Performance of Cxbladder Resolve, Alone and in Combination with Other Cxbladder Tests, in the Identification and Priority Evaluation of Patients at Risk for Urothelial Carcinoma.
Raman JD; Kavalieris L; Konety B; Porten S; Daneshmand S; Lotan Y; Loo R
J Urol; 2021 Dec; 206(6):1380-1389. PubMed ID: 34348469
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Cxbladder and Adjudication of Atypical Cytology and Equivocal Cystoscopy.
Konety B; Shore N; Kader AK; Porten S; Daneshmand S; Lough T; Lotan Y
Eur Urol; 2019 Aug; 76(2):238-243. PubMed ID: 31103391
[TBL] [Abstract][Full Text] [Related]
8. Clinical utility of a non-invasive urine test for risk assessing patients with no obvious benign cause of hematuria: a physician-patient real world data analysis.
Lough T; Luo Q; Luxmanan C; Anderson A; Suttie J; O'Sullivan P; Darling D
BMC Urol; 2018 Mar; 18(1):18. PubMed ID: 29523118
[TBL] [Abstract][Full Text] [Related]
9. A Urine Based Genomic Assay to Triage Patients with Hematuria for Cystoscopy.
van Kessel KEM; de Jong JJ; Ziel-van der Made ACJ; Roshani H; Haensel SM; Wolterbeek JH; Boevé ER; Oomens EHGM; van Casteren NJ; Krispin M; Boormans JL; Steyerberg EW; van Criekinge W; Zwarthoff EC
J Urol; 2020 Jul; 204(1):50-57. PubMed ID: 31985322
[TBL] [Abstract][Full Text] [Related]
10. Clinical Utility of Cxbladder for the Diagnosis of Urothelial Carcinoma.
Darling D; Luxmanan C; O'Sullivan P; Lough T; Suttie J
Adv Ther; 2017 May; 34(5):1087-1096. PubMed ID: 28341930
[TBL] [Abstract][Full Text] [Related]
11. A segregation index combining phenotypic (clinical characteristics) and genotypic (gene expression) biomarkers from a urine sample to triage out patients presenting with hematuria who have a low probability of urothelial carcinoma.
Kavalieris L; O'Sullivan PJ; Suttie JM; Pownall BK; Gilling PJ; Chemasle C; Darling DG
BMC Urol; 2015 Mar; 15():23. PubMed ID: 25888331
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic yield of repeat evaluation for asymptomatic microscopic hematuria after negative initial workup.
Pak JS; Wang EY; Lee K; Pina LA; McKiernan JM; Anderson CB
Urol Oncol; 2021 May; 39(5):300.e1-300.e6. PubMed ID: 33339726
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of diagnostic strategies for bladder cancer using computed tomography (CT) urography, flexible cystoscopy and voided urine cytology: results for 778 patients from a hospital haematuria clinic.
Blick CG; Nazir SA; Mallett S; Turney BW; Onwu NN; Roberts IS; Crew JP; Cowan NC
BJU Int; 2012 Jul; 110(1):84-94. PubMed ID: 22122739
[TBL] [Abstract][Full Text] [Related]
14. A multigene urine test for the detection and stratification of bladder cancer in patients presenting with hematuria.
O'Sullivan P; Sharples K; Dalphin M; Davidson P; Gilling P; Cambridge L; Harvey J; Toro T; Giles N; Luxmanan C; Alves CF; Yoon HS; Hinder V; Masters J; Kennedy-Smith A; Beaven T; Guilford PJ
J Urol; 2012 Sep; 188(3):741-7. PubMed ID: 22818138
[TBL] [Abstract][Full Text] [Related]
15. [The evaluation of cystoscopy in the screening of asymptomatic microhematuria].
Hattori R; Matsuura O; Takeuchi N; Hashimoto J; Ohshima S; Ono Y; Yamada S; Kinukawa T; Miyake K
Nihon Hinyokika Gakkai Zasshi; 1991 May; 82(5):810-5. PubMed ID: 1875575
[TBL] [Abstract][Full Text] [Related]
16. A Prospective Blinded Evaluation of Urine-DNA Testing for Detection of Urothelial Bladder Carcinoma in Patients with Gross Hematuria.
Dahmcke CM; Steven KE; Larsen LK; Poulsen AL; Abdul-Al A; Dahl C; Guldberg P
Eur Urol; 2016 Dec; 70(6):916-919. PubMed ID: 27417036
[TBL] [Abstract][Full Text] [Related]
17. The Prevalence of Bladder Cancer During Cystoscopy for Asymptomatic Microscopic Hematuria.
Gonzalez AN; Lipsky MJ; Li G; Rutman MP; Cooper KL; Weiner DM; Badalato G; Decastro GJ; Wenske S; McKiernan JM; Anderson CB
Urology; 2019 Apr; 126():34-38. PubMed ID: 30677457
[TBL] [Abstract][Full Text] [Related]
18. An evaluation of the real world use and clinical utility of the Cxbladder Monitor assay in the follow-up of patients previously treated for bladder cancer.
Koya M; Osborne S; Chemaslé C; Porten S; Schuckman A; Kennedy-Smith A
BMC Urol; 2020 Feb; 20(1):12. PubMed ID: 32046687
[TBL] [Abstract][Full Text] [Related]
19. Newly diagnosed bladder cancer: the relationship of initial symptoms, degree of microhematuria and tumor marker status.
Boman H; Hedelin H; Jacobsson S; Holmäng S
J Urol; 2002 Nov; 168(5):1955-9. PubMed ID: 12394684
[TBL] [Abstract][Full Text] [Related]
20. A Urine-based Genomic Assay Improves Risk Stratification for Patients with High-risk Hematuria Stratified According to the American Urological Association Guidelines.
de Jong JJ; Pijpers OM; van Kessel KEM; Boormans JL; Van Criekinge W; Zwarthoff EC; Lotan Y
Eur Urol Oncol; 2023 Apr; 6(2):183-189. PubMed ID: 36089502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
